S. Weidinger, “Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial”, J of Skin, vol. 4, no. 6, p. s102, Oct. 2020.